Tellurian (NYSE:TELL) rose 1.6% in after hours buying and selling after its deliberate sale to Australia’s Woodside Vitality (WDS) received US nationwide safety approval.
The Committee on International Funding in the US knowledgeable Tellurian (TELL) that it accepted the sale to Woodside (